These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15324824)

  • 1. Levetiracetam as add-on therapy in generalised epilepsies.
    Kumar SP; Smith PE
    Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam monotherapy for primary generalised epilepsy.
    Cohen J
    Seizure; 2003 Apr; 12(3):150-3. PubMed ID: 12651079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.
    Labate A; Colosimo E; Gambardella A; Leggio U; Ambrosio R; Quattrone A
    Seizure; 2006 Apr; 15(3):214-8. PubMed ID: 16420982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy.
    Rocamora R; Wagner K; Schulze-Bonhage A
    Seizure; 2006 Sep; 15(6):428-33. PubMed ID: 16837220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
    Goldberg-Stern H; Feldman L; Eidlitz-Markus T; Kramer U; Perez S; Pollak L; Phatal-Valevski A
    Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy.
    Weber S; Beran RG
    J Clin Neurosci; 2004 Sep; 11(7):728-31. PubMed ID: 15337134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
    Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
    Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G; Szucs A
    Ideggyogy Sz; 2007 Jan; 60(1-2):31-4. PubMed ID: 17432091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
    Lagae L; Buyse G; Ceulemans B
    Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.
    Noachtar S; Andermann E; Meyvisch P; Andermann F; Gough WB; Schiemann-Delgado J;
    Neurology; 2008 Feb; 70(8):607-16. PubMed ID: 18285535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of levetiracetam for partial seizures.
    Abou-Khalil B; Schaich L
    Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levetiracetam in refractory childhood epilepsy syndromes.
    Lagae L; Buyse G; Deconinck A; Ceulemans B
    Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.